IRON - CIK 0001816736
Disc Medicine, Inc. trades as IRON and has a market capitalization of $2.59 B, making it the #1921 largest US-listed company by market value. This page tracks Disc Medicine, Inc. through 704 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-05 |
| Major company event | 8-K | 2026-05-05 |
| Annual report to shareholders | ARS | 2026-04-28 |
| Proxy materials | DEFA14A | 2026-04-28 |
| Proxy statement | DEF 14A | 2026-04-28 |
| Insider trade | 4 | 2026-04-15 |
| Insider trade | 4 | 2026-04-15 |
| Insider sale notice | 144 | 2026-04-13 |
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress | Disc Medicine Inc.
Disc Medicine to Participate in Upcoming Investor Conferences | Disc Medicine Inc.
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update | Disc Medicine Inc.
Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting | Disc Medicine Inc.
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria | Disc Medicine Inc.
The largest companies sharing Disc Medicine, Inc.'s SEC industry classification (pharmaceutical preparations).
Disc Medicine, Inc. (IRON) has a market capitalization of $2.59 B as of 2026-06-10, ranking #1921 among US-listed companies.
In its latest fiscal year Disc Medicine, Inc. reported a net loss of $212.18M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.